期刊文献+

Eales病患者血清中T淋巴细胞因子的检测及临床分析 被引量:1

Detection of serum T lymphocytes cytokines of patients with Eales disease and its clinical significance
下载PDF
导出
摘要 目的检测Eales病患者血清中的T淋巴细胞(T细胞)因子。方法采用Luminex技术分别检测Eales病首发病例组、治愈病例组和健康对照组血清中辅助性T细胞1(TH1)亚群分泌的肿瘤坏死因子α(TNF-α)、干扰素γ(IFN-γ)和Th2细胞亚群分泌的白细胞介素4(IL-4)的浓度变化。结果 TNF-α在首发病例组、治愈病例组和健康对照组的浓度分别为(23.08±0.22)、(12.36±0.16)、(12.38±0.13)pg/m L;IFN-γ的浓度分别为(18.23±0.26)、(7.07±0.19)、(6.66±0.22)pg/m L。首发病例组和治愈病例组(P<0.001),首发病例组和健康对照组(P<0.001),治愈病例组和健康对照组(P=0.04),各组比较差异均有统计学意义。IL-4在首发病例组、治愈病例组和健康对照组的浓度分别为(4.18±0.19)、(4.16±0.13)、(4.15±0.12)pg/m L。首发病例组和治愈病例组(P=0.03),首发病例组和健康对照组(P=0.01),各组比较差异均有统计学意义;治愈病例组和健康对照组(P=0.79)差异无统计学意义。Th1和Th2细胞代表因子的比值IFN-γ/IL-4在首发病例组、治愈病例组和健康对照组分别为4.26±0.11、1.70±0.08和1.49±0.06。首发病例组与治愈病例组(P<0.001),首发病例组与健康对照组(P<0.001),治愈病例组与健康对照组(P=0.02),各组比较差异均有统计学意义。结论 Eales病患者血清中T细胞因子的浓度均有不同程度升高,且Th1/Th2比值升高。可见Th1亚群分泌的细胞因子占优势,可以证明T细胞亚群的失衡参与了Eales病的免疫机制。 Objective To detect the serum T lymphocytes cytokine of patients with Eales disease. Methods Luminex technique was used to detect the concentration changes of tumour necrosis factor α( TNF-α) and interferon γ( IFN-γ) secreted by helper T cells 1( Th1) subset and interleukin 4( IL-4) secreted by Th2 subset in the serum of patients with Eales disease untreated group,cured group and healthy control group. Results The concentrations of TNF-α in untreated group,cured group and healthy control group were( 23. 08 ± 0. 22),( 12. 36 ± 0. 16),( 12. 38 ±0. 13) pg / m L,respectively; the concentrations of IFN-γ in untreated group,cured group and healthy control group were( 18. 23 ±0. 26),( 7. 07 ±0. 19),( 6. 66 ±0. 22) pg/m L,respectively. The differences of the concentration of TNF-αand IFN-γ between untreated group and cured group( P 0. 001),untreated group and healthy control group( P 0. 001),cured group and healthy control group( P = 0. 04),were statistically significant. The concentrations of IL-4 in untreated group,cured group and healthy control group were( 4. 18 ± 0. 19),( 4. 16 ± 0. 13),( 4. 15 ± 0. 12),respectively. The differences of the concentration of IL-4 between untreated group and cured group( P = 0. 03),untreated group and healthy control group( P = 0. 01) were statistically significant. While the difference was not statistically significant between cured group and healthy control group( P = 0. 79). The ratios of representative factors( IFN-γ/ IL-4) of Th1 and Th2 in untreated group,cured group and healthy control group were 4. 26 ± 0. 11,1. 70 ±0. 08 and 1. 49 ± 0. 06,respectively. The differences of the ratio between untreated group and cured group( P 0. 001),untreated group and healthy control group( P 0. 001),cured group and healthy control group( P = 0. 02) were statistically significant. Conclusions Concentrations of T lymphocytes cytokines in the serum of Eales disease of patients are increased at diferent degrees,and the Th1 / Th2 ratio is also increased,which indicates the domination of cytokines secreted by Th1 subset. The imbalance of T lymphocyte subsets participates in the immunological mechanism of Eales disease.
出处 《中国眼耳鼻喉科杂志》 2016年第2期99-102,共4页 Chinese Journal of Ophthalmology and Otorhinolaryngology
基金 宁波市医学科技计划项目(2010A16)
关键词 EALES病 免疫因子 LUMINEX Eales disease Immune factors Luminex
  • 相关文献

参考文献18

  • 1Cp J, A1 G, Jd L. Combination of intravitreal bevacizumab and peripheral photoeoagulation : an alternative treatment in Eales disease [ J ]. Med Hypothesis Discov Innov Ophthalmo1,2013,2 (2) :30-34.
  • 2Fung AT, Nicolc M, Yzer S, et al. Eales disease associated with serpiginous choroiditis [ J ]. Arch Ophthalmol, 2012, 130 ( 11 ) : 1484-1486.
  • 3Bharathselvi M, Biswas J, Selvi R, et al. Increased homocysteine, homocysteine-thiolactone, protein honmcysteinylation and oxidative stress in the circulation of patients with Eales" disease [ J ]. Ann Clin Bioehem ,2013,50 ( Pt 4 ) :330-338.
  • 4Groen B, Links TP, Lefrandt JD, et al. Aberrant pregnancy adaptations in the peripheral immune response in type 1 diabetes: a rat model [ J ]. PLoS One, 2013,8 ( 6 ) : e65490.
  • 5Talaat RM, Mohamed SF, Bassyouni IH,et al. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity [ J ]. Cytokine, 2015, 72 ( 2 ) : 146-153.
  • 6Lina C, Conghua W, Nan L,et al. Combined treatment of etanercept and MTX reverses Thl/Th2, Thl7/Treg imbalance in patients with rheumatoid arthritis [ J ]. J Clin Immunol,2011,31 (4) :596-605.
  • 7Biswas J , Sharma T, Gopal L , et al. Eales disease- an update [ J ]. Surv Ophthalmol, 2002, 47 (3) : 197-213.
  • 8Tang F, Wang F, An L,et al. Upregulation of Tim-3 on CIM( + ) T cells is associated with Thl/Th2 imbalance in patients with allergic asthma[ J ]. Int J Clin Exp Med ,2015,8 (3) :3809-3816.
  • 9Nishikawa M, Owaki H, Kaneshiro S, et aL Eight-year preservation of knee function with radiographic healing phenomena after anti- tumornecrosis factor-α therapy for a severely erosive knee in a young patient with rheumatoid arthritis [ J ]. Acta Reumatol Port, 2015,40 ( 1 ) :72-76.
  • 10Chang PC, Chen TH, Chang C J, et al. Advanced glycosylation end products Induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK dependent pathway [J]. Kidney Int, 2004, 65 (5) :1664-1675.

二级参考文献14

  • 1吴茜茜,卢洁,潘建平.白细胞介素23研究进展[J].国外医学(流行病学.传染病学分册),2005,32(4):236-239. 被引量:5
  • 2谭广,王忠裕.白细胞介素-23的研究进展[J].国际检验医学杂志,2006,27(10):894-895. 被引量:2
  • 3Masuda M, Wakasaki T, Suzui M, et al. STAT3 orchestrates tumor development and progression: the Achilles" heel of head and neck cancers ? [J]. Curt Cancer Drug Targets,2010,10(1) :117-126.
  • 4Johnston PA, Grandis JR. STA33 SIGNALING : anticancer strategies and challenges [ J ]. Mol Interv ,2011,11 ( 1 ) : 18-26.
  • 5Ghoshal GS, Baumann H, Wetzler M. Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia [J]. Leuk Res,2008,32(7) :1005-1014.
  • 6Lee I, Fox PS, Ferguson SD, et al. The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival J l- Oncotarget ,2012,3 ( 3 ) :336-44.
  • 7Dien J, Amin HM, Chiu N, et al. Signal transdueers and acti-vators of transcription 3 up-regulates tissue inhibitor of metallo- proteinase-1 expression and decreases invasiveness of breast cancer [ J 1. Am J Pathol, 2006,169 ( 2 ) : 633 -642.
  • 8Hayes SH, Seigel GM. Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues E J ]. Int J Clin Exp Pathol, 2009,2 (6) :553-560.
  • 9Gogali A, Charalabopoulos K, Zampira I. Soluble adhesion molecules E-eadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers J ]. Chest ,2010,138 ( 5 ) : 1173-1179.
  • 10Dymicka PV, Kemona H. Does eolorectal cancer clinical advancement affect adhesion molecules ( sP-selectin, sE-seleetin and ICAM-1 ) concentration? [ J ]. Thromb Ptes,2009,124 ( 1 ) :80-83.

共引文献6

同被引文献33

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部